nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSK—osteoarthritis	0.765	1	CbGaD
Boceprevir—CTSK—skeletal joint—osteoarthritis	0.0107	0.204	CbGeAlD
Boceprevir—CTSK—leg—osteoarthritis	0.00819	0.156	CbGeAlD
Boceprevir—CTSK—forelimb—osteoarthritis	0.00813	0.154	CbGeAlD
Boceprevir—CTSK—hindlimb—osteoarthritis	0.00732	0.139	CbGeAlD
Boceprevir—CTSK—cartilage tissue—osteoarthritis	0.0072	0.137	CbGeAlD
Boceprevir—Telaprevir—CTSK—osteoarthritis	0.00717	1	CrCbGaD
Boceprevir—CTSS—synovial membrane of synovial joint—osteoarthritis	0.00713	0.135	CbGeAlD
Boceprevir—CTSL—tendon—osteoarthritis	0.00163	0.031	CbGeAlD
Boceprevir—CTSK—tendon—osteoarthritis	0.00123	0.0234	CbGeAlD
Boceprevir—CTSS—tendon—osteoarthritis	0.00108	0.0205	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—COL10A1—osteoarthritis	0.000472	0.00269	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FMOD—osteoarthritis	0.000472	0.00269	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—ADAMTS5—osteoarthritis	0.000444	0.00253	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—ADAMTS3—osteoarthritis	0.000444	0.00253	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP13—osteoarthritis	0.000438	0.00249	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—TIMP1—osteoarthritis	0.000437	0.00249	CbGpPWpGaD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP9—osteoarthritis	0.000432	0.00246	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP3—osteoarthritis	0.00043	0.00245	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP3—osteoarthritis	0.00043	0.00245	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP3—osteoarthritis	0.00043	0.00245	CbGpPWpGaD
Boceprevir—CTSS—MHC class II antigen presentation—CTSK—osteoarthritis	0.000426	0.00243	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL10A1—osteoarthritis	0.000421	0.0024	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP13—osteoarthritis	0.000418	0.00238	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP2—osteoarthritis	0.000415	0.00237	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP3—osteoarthritis	0.00041	0.00234	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP3—osteoarthritis	0.00041	0.00234	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COMP—osteoarthritis	0.000408	0.00232	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—GDF5—osteoarthritis	0.000408	0.00232	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.000406	0.00231	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.000406	0.00231	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP9—osteoarthritis	0.000402	0.00229	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ADAMTS5—osteoarthritis	0.000396	0.00225	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ADAMTS3—osteoarthritis	0.000396	0.00225	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FMOD—osteoarthritis	0.000389	0.00221	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP3—osteoarthritis	0.000381	0.00217	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.000377	0.00215	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP9—osteoarthritis	0.000377	0.00215	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL9A2—osteoarthritis	0.000373	0.00212	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL9A2—osteoarthritis	0.000373	0.00212	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL9A1—osteoarthritis	0.000362	0.00206	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL9A1—osteoarthritis	0.000362	0.00206	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—TIMP1—osteoarthritis	0.00036	0.00205	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP9—osteoarthritis	0.000358	0.00204	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL10A1—osteoarthritis	0.000346	0.00197	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL9A2—osteoarthritis	0.000346	0.00197	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—IGF1—osteoarthritis	0.000341	0.00194	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP3—osteoarthritis	0.00034	0.00194	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL9A1—osteoarthritis	0.000336	0.00192	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.000336	0.00192	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CTSK—osteoarthritis	0.000329	0.00187	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000328	0.00187	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000328	0.00187	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ADAMTS3—osteoarthritis	0.000326	0.00186	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ADAMTS5—osteoarthritis	0.000326	0.00186	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—BGN—osteoarthritis	0.000317	0.00181	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—BGN—osteoarthritis	0.000317	0.00181	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP9—osteoarthritis	0.000312	0.00178	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL9A2—osteoarthritis	0.000309	0.00176	CbGpPWpGaD
Boceprevir—CMA1—Peptide hormone metabolism—LEP—osteoarthritis	0.000306	0.00174	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000305	0.00174	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—COL2A1—osteoarthritis	0.000302	0.00172	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—COL2A1—osteoarthritis	0.000302	0.00172	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL9A1—osteoarthritis	0.0003	0.00171	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—BGN—osteoarthritis	0.000295	0.00168	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—MMP9—osteoarthritis	0.000293	0.00167	CbGpPWpGaD
Boceprevir—CTSL—Assembly of collagen fibrils and other multimeric structures—MMP9—osteoarthritis	0.000293	0.00167	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP3—osteoarthritis	0.000293	0.00167	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CTSK—osteoarthritis	0.000292	0.00166	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CTSK—osteoarthritis	0.000292	0.00166	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—COL2A1—osteoarthritis	0.000281	0.0016	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP3—osteoarthritis	0.00028	0.00159	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—ADAMTS4—osteoarthritis	0.000277	0.00158	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000272	0.00155	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—CTSK—osteoarthritis	0.000271	0.00154	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—BGN—osteoarthritis	0.000263	0.0015	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP13—osteoarthritis	0.000257	0.00146	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP13—osteoarthritis	0.000257	0.00146	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL9A2—osteoarthritis	0.000254	0.00145	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000254	0.00145	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000254	0.00145	CbGpPWpGaD
Boceprevir—CMA1—Peptide hormone metabolism—IGF1—osteoarthritis	0.000253	0.00144	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—COL2A1—osteoarthritis	0.00025	0.00143	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—MMP9—osteoarthritis	0.000248	0.00141	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—BMP2—osteoarthritis	0.000248	0.00141	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—BMP2—osteoarthritis	0.000248	0.00141	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL9A1—osteoarthritis	0.000247	0.00141	CbGpPWpGaD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—HSPA5—osteoarthritis	0.000241	0.00137	CbGpPWpGaD
Boceprevir—CTSL—Class I MHC mediated antigen processing & presentation—HSPA5—osteoarthritis	0.000241	0.00137	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP13—osteoarthritis	0.000239	0.00136	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000236	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—BMP2—osteoarthritis	0.000231	0.00131	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP1—osteoarthritis	0.000224	0.00127	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TIMP1—osteoarthritis	0.000221	0.00126	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TIMP1—osteoarthritis	0.000221	0.00126	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000221	0.00126	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ADAMTS13—osteoarthritis	0.000221	0.00126	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—BGN—osteoarthritis	0.000216	0.00123	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP13—osteoarthritis	0.000213	0.00121	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.00021	0.0012	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ADAMTS5—osteoarthritis	0.000207	0.00118	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ADAMTS3—osteoarthritis	0.000207	0.00118	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—COL2A1—osteoarthritis	0.000206	0.00117	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TIMP1—osteoarthritis	0.000205	0.00117	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—BMP2—osteoarthritis	0.000205	0.00117	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—TGFB1—osteoarthritis	0.000205	0.00117	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—MMP9—osteoarthritis	0.0002	0.00114	CbGpPWpGaD
Boceprevir—CTSL—Collagen formation—MMP9—osteoarthritis	0.0002	0.00114	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—MMP9—osteoarthritis	0.0002	0.00114	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CTSK—osteoarthritis	0.000199	0.00113	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.000191	0.00109	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.000191	0.00109	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—osteoarthritis	0.000186	0.00106	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TIMP1—osteoarthritis	0.000183	0.00104	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.000177	0.00101	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—ADAMTS4—osteoarthritis	0.000176	0.001	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP13—osteoarthritis	0.000175	0.000998	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP2—osteoarthritis	0.000173	0.000986	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP3—osteoarthritis	0.000172	0.000979	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP3—osteoarthritis	0.000172	0.000979	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—BMP2—osteoarthritis	0.000169	0.000964	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—HSPA5—osteoarthritis	0.000164	0.000936	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP3—osteoarthritis	0.00016	0.00091	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.000158	0.0009	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTSK—osteoarthritis	0.000156	0.000889	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CTSK—osteoarthritis	0.000156	0.000889	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TIMP1—osteoarthritis	0.000151	0.000859	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CTSK—osteoarthritis	0.00015	0.000853	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CTSK—osteoarthritis	0.00015	0.000853	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP3—osteoarthritis	0.000142	0.000811	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP1—osteoarthritis	0.000137	0.000783	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP1—osteoarthritis	0.000137	0.000783	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—MMP9—osteoarthritis	0.000136	0.000776	CbGpPWpGaD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP9—osteoarthritis	0.00013	0.000741	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP1—osteoarthritis	0.000128	0.000728	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—FN1—osteoarthritis	0.000125	0.000714	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—FN1—osteoarthritis	0.000125	0.000714	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—MMP9—osteoarthritis	0.000123	0.000699	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HSPA5—osteoarthritis	0.000119	0.000679	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HSPA5—osteoarthritis	0.000119	0.000679	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP3—osteoarthritis	0.000117	0.000668	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—FN1—osteoarthritis	0.000117	0.000664	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP1—osteoarthritis	0.000114	0.000649	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTSK—osteoarthritis	0.000106	0.000606	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP2—osteoarthritis	0.000106	0.000606	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP2—osteoarthritis	0.000106	0.000606	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—FN1—osteoarthritis	0.000104	0.000592	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CTSK—osteoarthritis	0.000102	0.000582	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—HSPA5—osteoarthritis	0.000101	0.000574	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP2—osteoarthritis	9.89e-05	0.000563	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HSPA5—osteoarthritis	9.88e-05	0.000563	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MCF2L—osteoarthritis	9.51e-05	0.000542	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IHH—osteoarthritis	9.51e-05	0.000542	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP1—osteoarthritis	9.38e-05	0.000534	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTSK—osteoarthritis	9.09e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CAMK2B—osteoarthritis	9.09e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CAMK2B—osteoarthritis	9.09e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTSK—osteoarthritis	9.09e-05	0.000518	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP2—osteoarthritis	8.81e-05	0.000502	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—FN1—osteoarthritis	8.56e-05	0.000487	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—IL6—osteoarthritis	8.2e-05	0.000467	CbGpPWpGaD
Boceprevir—CTSL—Toll-Like Receptors Cascades—IL6—osteoarthritis	8.2e-05	0.000467	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HSPA5—osteoarthritis	8.13e-05	0.000463	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—MMP9—osteoarthritis	7.99e-05	0.000455	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP9—osteoarthritis	7.99e-05	0.000455	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—IL6—osteoarthritis	7.62e-05	0.000434	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CAMK2B—osteoarthritis	7.53e-05	0.000429	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—MMP9—osteoarthritis	7.43e-05	0.000423	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CRP—osteoarthritis	7.27e-05	0.000414	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CRP—osteoarthritis	7.27e-05	0.000414	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP2—osteoarthritis	7.26e-05	0.000413	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HSPA5—osteoarthritis	7.23e-05	0.000412	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HSPA5—osteoarthritis	7.23e-05	0.000412	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1RN—osteoarthritis	7.04e-05	0.000401	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1RN—osteoarthritis	7.04e-05	0.000401	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—COL9A2—osteoarthritis	6.98e-05	0.000398	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTO1—osteoarthritis	6.87e-05	0.000391	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—osteoarthritis	6.79e-05	0.000387	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—COL9A1—osteoarthritis	6.78e-05	0.000386	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTO1—osteoarthritis	6.78e-05	0.000386	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—osteoarthritis	6.62e-05	0.000377	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—osteoarthritis	6.59e-05	0.000375	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—osteoarthritis	6.59e-05	0.000375	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTSK—osteoarthritis	6.2e-05	0.000353	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CAMK2B—osteoarthritis	6.2e-05	0.000353	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—osteoarthritis	6.12e-05	0.000349	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—osteoarthritis	6.02e-05	0.000343	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HSPA5—osteoarthritis	5.99e-05	0.000341	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP1—osteoarthritis	5.97e-05	0.00034	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1RN—osteoarthritis	5.83e-05	0.000332	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—LEP—osteoarthritis	5.78e-05	0.000329	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—osteoarthritis	5.59e-05	0.000319	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—osteoarthritis	5.46e-05	0.000311	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—osteoarthritis	5.45e-05	0.000311	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	5.3e-05	0.000302	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1A—osteoarthritis	5.06e-05	0.000288	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1A—osteoarthritis	5.06e-05	0.000288	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—osteoarthritis	4.96e-05	0.000283	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HSPA5—osteoarthritis	4.93e-05	0.000281	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1RN—osteoarthritis	4.8e-05	0.000273	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1A—osteoarthritis	4.8e-05	0.000273	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—IGF1—osteoarthritis	4.78e-05	0.000272	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BMP2—osteoarthritis	4.64e-05	0.000265	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP2—osteoarthritis	4.62e-05	0.000263	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	4.53e-05	0.000258	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—osteoarthritis	4.49e-05	0.000256	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—osteoarthritis	4.23e-05	0.000241	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—osteoarthritis	4.23e-05	0.000241	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1A—osteoarthritis	4.2e-05	0.000239	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—osteoarthritis	3.84e-05	0.000219	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CRP—osteoarthritis	3.51e-05	0.0002	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1A—osteoarthritis	3.46e-05	0.000197	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP3—osteoarthritis	3.22e-05	0.000183	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	3.19e-05	0.000182	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	3.15e-05	0.000179	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SMAD3—osteoarthritis	2.91e-05	0.000166	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CRP—osteoarthritis	2.89e-05	0.000165	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—osteoarthritis	2.66e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—osteoarthritis	2.66e-05	0.000151	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—osteoarthritis	2.64e-05	0.00015	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—osteoarthritis	2.64e-05	0.00015	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	2.61e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—osteoarthritis	2.5e-05	0.000143	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—osteoarthritis	2.49e-05	0.000142	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ESR1—osteoarthritis	2.38e-05	0.000135	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FN1—osteoarthritis	2.35e-05	0.000134	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—osteoarthritis	2.2e-05	0.000125	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—osteoarthritis	2.19e-05	0.000125	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—osteoarthritis	2.06e-05	0.000117	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FMOD—osteoarthritis	2.05e-05	0.000117	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	1.94e-05	0.000111	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	1.85e-05	0.000105	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—osteoarthritis	1.82e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—osteoarthritis	1.81e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—osteoarthritis	1.8e-05	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGES—osteoarthritis	1.67e-05	9.5e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—osteoarthritis	1.65e-05	9.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	1.6e-05	9.12e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—osteoarthritis	1.55e-05	8.81e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—osteoarthritis	1.55e-05	8.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FMOD—osteoarthritis	1.54e-05	8.79e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—osteoarthritis	1.5e-05	8.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	1.33e-05	7.56e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—osteoarthritis	1.28e-05	7.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGES—osteoarthritis	1.26e-05	7.17e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—osteoarthritis	1.23e-05	7.03e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTO1—osteoarthritis	1.18e-05	6.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BGN—osteoarthritis	1.14e-05	6.48e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—osteoarthritis	1.06e-05	6.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	9.6e-06	5.47e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FMOD—osteoarthritis	9.51e-06	5.42e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—osteoarthritis	9.3e-06	5.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	8.96e-06	5.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTO1—osteoarthritis	8.87e-06	5.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BGN—osteoarthritis	8.59e-06	4.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGES—osteoarthritis	7.75e-06	4.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTO1—osteoarthritis	5.46e-06	3.11e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BGN—osteoarthritis	5.29e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—osteoarthritis	3.27e-06	1.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—osteoarthritis	2.47e-06	1.41e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—osteoarthritis	1.52e-06	8.66e-06	CbGpPWpGaD
